Title of article :
Corrigendum to ‘‘An overview of the preclinical toxicity and potential carcinogenicity of sitaxentan (Thelin®), a potent endothelin receptor antagonist developed for pulmonary arterial hypertension” [Regul. Toxicol. Pharmacol. 2012, 95–103]
Author/Authors :
Owen، نويسنده , , Keith and Cross، نويسنده , , David M. and Derzi، نويسنده , , Mazin and Horsley، نويسنده , , Elizabeth and Stavros، نويسنده , , Fiona L.، نويسنده ,
